The impact of RNA standardization and heterogeneous gene expression on the results of cDNA array of human breast carcinoma

International Journal of Molecular Medicine

Volumn 25, Issue 5, 2010, Pages 735-741

  Khoshnoud, Reza ^a   He, Qimin ^b,c   Sylván, Maria ^a   Khoshnoud, Aida ^b   Ivarsson, Madleen ^b   Fornander, Tommy ^a   Bergh, Jonas ^a   Frisell, Jan ^a   Rutqvist, Lars Erik ^b   Skog, Sven ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Novum   (Sweden)

^c Sino Swed Molecular Bio Medicine Research Institute   (China)

Author keywords

cDNA array; Degradation of RNA; Human breast carcinoma; mRNA; RNA

Indexed keywords

COMPLEMENTARY DNA; RNA;

ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL; CELL HETEROGENEITY; CELL ISOLATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HOSPITAL SERVICE; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MICRODISSECTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRODISSECTION; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA;

EID: 77951707401     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000399     Document Type: Article

References (47)

1. Hayes DF, Bast RC, Desch CE, et al: Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88: 1456-1466, 1996.
2. Pawitan Y, Bjohle J, Amler L, et al: Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-R964, 2005.
3. Hayes DF, Trock B and Harris AL: Assessing the clinical impact of prognostic factors: when is 'statistically significant' clinically useful? Breast Cancer Res Treat 52: 305-319, 1998.
4. Marx J: DNA arrays reveal cancer in its many forms. Science 289: 1670-1672, 2000.
5. Richmond CS, Glasner JD, Mau R, Jin H and Blattner FR: Genome-wide expression profiling in Escherichia coli K-12. Nucleic Acids Res 27: 3821-3835, 1999.
6. Carulli JP, Artinger M, Swain PM, et al: High throughput analysis of differential gene expression. J Cell Biochem 30-31: S286-S296, 1998. (Pubitemid 29028752)
7. Cox JM: Applications of nylon membrane arrays to gene expression analysis. J Immunol Methods 250: 3-13, 2001.
8. Wang GL and Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90: 4304-4308, 1993.
9. Wenger RH, Rolfs A, Marti HH, Bauer C and Gassmann M: Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J Biol Chem 270: 27865-27870, 1995.
10. Helfman T and Falanga V: Gene expression in low oxygen tension. Am J Med Sci 306: 37-41, 1993. (Pubitemid 23198471)
11. Fandrey J: Hypoxia-inducible gene expression. Respir Physiol 101: 1-10, 1995.
12. Goldberg MA and Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269: 4355-4359, 1994.
13. Marchuk L, Sciore P, Reno C, Frank CB and Hart DA: Post-mortem stability of total RNA isolated from rabbit ligament, tendon and cartilage. Biochim Biophys Acta 1379: 171-177, 1998. (Pubitemid 28252892)
14. Von Euler H, Khoshnoud R, He Q, et al: Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. Int J Mol Med 16: 979-985, 2005.
15. Zhu G, Reynolds L, Crnogorac-Jurcevic T, et al: Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene 22: 3742-3748, 2003. (Pubitemid 36760736)
16. Skog S, He Q, Khoshnoud R, Fornander T and Rutqvist LE: Genes related to growth regulation, DNA repair and apoptosis in an oestrogen receptor-negative (MDA-231) versus an oestrogen receptor-positive (MCF-7) breast tumour cell line. Tumour Biol 25: 41-47, 2004.
17. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW and Vogelstein B: Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res 54: 3714-3717, 1994. (Pubitemid 24241185)
18. McDonnell TJ and Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254-256, 1991.
19. McDonnell TJ, Troncoso P, Brisbay SM, et al: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52: 6940-6944, 1992. (Pubitemid 23006303)
20. Chodosh LA: Expression of BRCA1 and BRCA2 in normal and neoplastic cells. J Mammary Gland Biol Neoplasia 3: 389-402, 1998. (Pubitemid 128515792)
21. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9: 444-450, 1995.
22. Gudas JM, Li T, Nguyen H, Jensen D, Rauscher FJ III and Cowan KH: Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 7: 717-723, 1996. (Pubitemid 26360740)
23. Vaughn JP, Davis PL, Jarboe MD, et al: BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 7: 711-715, 1996.
24. Giricz O, Lauer-Fields JL and Fields GB: The normalization of gene expression data in melanoma: investigating the use of glyceraldehyde 3-phosphate dehydrogenase and 18S ribosomal RNA as internal reference genes for quantitative real-time PCR. Anal Biochem 380: 137-139, 2008.
25. Bereta J and Bereta M: Stimulation of glyceraldehyde-3-phosphate dehydrogenase mRNA levels by endogenous nitric oxide in cytokine-activated endothelium. Biochem Biophys Res Commun 217: 363-369, 1995. (Pubitemid 26004800)
26. Gibbs PJ, Cameron C, Tan LC, Sadek SA and Howell WM: House keeping genes and gene expression analysis in transplant recipients: a note of caution. Transpl Immunol 12: 89-97, 2003. (Pubitemid 37321509)
27. Hamalainen HK, Tubman JC, Vikman S, et al: Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative realtime RT-PCR. Anal Biochem 299: 63-70, 2001. (Pubitemid 33124128)
28. Lee PD, Sladek R, Greenwood CM and Hudson TJ: Control genes and variability: absence of ubiquitous reference transcripts in diverse mammalian expression studies. Genome Res 12: 292-297, 2002. (Pubitemid 34162995)
29. Fink L, Seeger W, Ermert L, et al: Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 4: 1329-1333, 1998. (Pubitemid 28512117)
30. Goldsworthy SM, Stockton PS, Trempus CS, Foley JF and Maronpot RR: Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Mol Carcinog 25: 86-91, 1999.
31. Sgroi DC, Teng S, Robinson G, LeVangie R, Hudson JR Jr and Elkahloun AG: In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 59: 5656-5661, 1999.
32. Michel C, Desdouets C, Sacre-Salem B, Gautier JC, Roberts R and Boitier E: Liver gene expression profiles of rats treated with clofibric acid: comparison of whole liver and laser capture microdissected liver. Am J Pathol 163: 2191-2199, 2003. (Pubitemid 37466464)
33. Luo L, Salunga RC, Guo H, et al: Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 5: 117-122, 1999. (Pubitemid 29051009)
34. Sugiyama Y, Sugiyama K, Hirai Y, Akiyama F and Hasumi K: Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol 117: 109-116, 2002. (Pubitemid 34052480)
35. de Bruin EC, van de Pas S, Lips EH, et al: Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics 6: 142, 2005. (Pubitemid 41554969)
36. Yang F, Foekens JA, Yu J, et al: Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways. Oncogene 25: 1413-1419, 2006. (Pubitemid 43336470)
37. Makino H, Uetake H, Danenberg K, Danenberg PV and Sugihara K: Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer. BMC Cancer 8: 210, 2008.
38. Nakamura T, Furukawa Y, Nakagawa H, et al: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23: 2385-2400, 2004. (Pubitemid 38496794)
39. Adib TR, Henderson S, Perrett C, et al: Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 90: 686-692, 2004. (Pubitemid 38297211)
40. Ono K, Tanaka T, Tsunoda T, et al: Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res 60: 5007-5011, 2000.
41. Huang JM, Lin TY, Chang D, Lin SL and Ying SY: Truncated Bcl-2, a potential pre-metastatic marker in prostate cancer. Biochem Biophys Res Commun 306: 912-917, 2003. (Pubitemid 36776216)
42. Katoh M: CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11: 683-689, 2003.
43. Kobayashi K, Nishioka M, Kohno T, et al: Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo. Oncogene 23: 3089-3096, 2004. (Pubitemid 38648199)
44. Kikuchi T, Daigo Y, Katagiri T, et al: Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22: 2192-2205, 2003. (Pubitemid 36539569)
45. Symmans WF, Ayers M, Clark EA, et al: Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer 97: 2960-2971, 2003. (Pubitemid 36676249)
46. Sotiriou C, Powles TJ, Dowsett M, et al: Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res 4: R3, 2002.
47. Assersohn L, Gangi L, Zhao Y, et al: The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. Clin Cancer Res 8: 794-801, 2002. (Pubitemid 34742110)